NASA, Health and Human Services Highlight Cancer Moonshot Progress
"We go to space not just to explore the stars, but to improve life here on Earth," said Nelson. "In that microgravity environment, NASA is studying cancer growth—and the effect of cancer treatments— much faster than we can on Earth. I am grateful for
Also participating in the event was Dr. W. Kimryn Rathmell, director of the National Cancer Institute, as well as NASA astronauts
As the second leading cause of death in
In addition to
"Eliminating cancer as we know it is a goal that unifies the country," said Becerra. "We all know someone, and most of us love someone, who has battled this terrible disease. As we did during the race to the Moon, we believe our technology and scientific community are capable of making the impossible a reality when it comes to ending cancer as we know it."
The backdrop for the event was NASA's Earth Information Center, which provides access to NASA satellites and other data to see how our planet is changing.
NASA is working with HHS and researchers across the federal government to help cut the nation's cancer death rate by at least 50% in the next 25 years, a goal of the Cancer Moonshot Initiative.
Learn more about Cancer Moonshot at:
https://www.whitehouse.gov/cancermoonshot/
View original content to download multimedia:https://www.prnewswire.com/news-releases/nasa-health-and-human-services-highlight-cancer-moonshot-progress-302096262.html
SOURCE NASA
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SCULLY ROYALTY BOARD OF DIRECTORS AND MANAGEMENT REMAIN UNCHANGED
- QpiAI Open-Sources Its Quantum SDK to Accelerate Global Quantum Software Development
- VALLOUREC CONFIRMS ITS INTENTION TO RETURN CLOSE TO €650 MILLION TO SHAREHOLDERS IN 2026 FOLLOWING THE COMPLETION OF ITS SHARE BUYBACK PROGRAM AND THE FULL EXERCISE OF THE WARRANTS
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share